Zero Federal Capital Gains Taxes on High Return Investments

With a new administration comes new perspectives and likely changes in tax policy. President Biden has proposed doubling the rate that wealthy Americans pay on investment capital gains up to 43.4%, a topic that has been...

Solenic Medical wins big at the 2021 Texas A&M New Ventures Competition

Solenic Medical participated in the 2021 Texas A&M New Ventures Competition (TNVC) held live at Texas A&M University after being held virtually in 2020. Twenty-one companies were invited to participate May 19-20 for...

Protecting Early Investors in Capital-Intensive Life Science Companies

Angel investors often invest at the seed stage of a company's development. The typically smaller round sizes and lower valuations allow early individual investors to gain a meaningful stake in a given company. However,...

Behind the Curtain | Single Family Offices and ESG Investing with Brian Cork

Brian Patrick Cork is a principal of brian cork COACHING™, which provides client services in business design, strategy development, executive team-building, and financial capital formation. Please tell us a little about...

VIC Announces Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC adds two life science leaders, bringing additional key insight to the team. VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively...

Nob Hill Therapeutics Adds Seasoned Life Science Expert Paul Atkins as Executive Chairman

Atkins will bring critical insight into the development and commercialization of inhaled medicines Albuquerque, NM - Southwest-based start-up Nob Hill Therapeutics is pleased to announce that Dr. Paul Atkins has been...

The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World

As discussed in my previous article “Portfolio Diversification During Times of Market Volatility,”[1] one of the few positive outcomes of the worldwide pandemic is the increasing recognition of the power of innovation...

Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion

Akeso Biomedical is pleased to announce that the European Food Safety Authority (EFSA) provided a positive scientific opinion for use of its CI-FER™ feed additive in weaners. The positive opinion was provided after the...

VIC Technology Venture Development Announces New Board of Directors Appointment

VIC Adds Acclaimed Life Science Veteran to Their Team. Fayetteville, AR - VIC Technology Venture Development announced today the appointment of Fenel M. Eloi, a seasoned executive in the life science sector, to their...

Inside CU Innovations: An Interview with Executive Director, Kim Muller

Kim Muller is the Executive Director of CU Innovations, the technology commercialization and venture development office at the University of Colorado’s Anschutz Medical and Denver campuses. We recently had a chance to...

FEATURED RESOURCES

News
Akeso Biomedical Announces European Food Safety Authority Positive Scientific Opinion
White Paper
Portfolio Diversification in Times of Market Volatility
Case Study
The Accelerating Pace of Life Science Innovation in a (Soon-to-Be) Post-Pandemic World
Updates
VIC 2020 Annual Report Executive Summary
News
CardioWise Receives US FDA 510(k) Clearance for Heart Function Analysis Software
Case Study
Opportunity Assessment: How To Vet So Much Tech
Interview
Inside CU Innovations: An Interview with Executive Director, Kim Muller
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
Updates
VIC Technology Venture Development Announces New Board of Directors Appointment
News
VIC Portfolio Company, BlueInGreen, Acquired by Chart Industries
Interview
VIC Fellows Spotlight: Travis Nemkov, PhD
From The Corner Office
Vixiar: Solving a Big Problem With a Small Device